222 related articles for article (PubMed ID: 7541890)
1. pH dependent binding of high and low affinity myelin basic protein peptides to purified HLA-DR2.
Mukku PV; Passmore D; Phan D; Nag B
Mol Immunol; 1995 Jun; 32(8):555-64. PubMed ID: 7541890
[TBL] [Abstract][Full Text] [Related]
2. Antigenic peptide binding to MHC class II molecules at increased peptide concentrations.
Nag B; Mukku PV; Arimilli S; Phan D; Deshpande SV; Winkelhake JL
Mol Immunol; 1994 Oct; 31(15):1161-8. PubMed ID: 7523870
[TBL] [Abstract][Full Text] [Related]
3. Refolding and reconstitution of functionally active complexes of human leukocyte antigen DR2 and myelin basic protein peptide from recombinant alpha and beta polypeptide chains.
Arimilli S; Cardoso C; Mukku P; Baichwal V; Nag B
J Biol Chem; 1995 Jan; 270(2):971-7. PubMed ID: 7529765
[TBL] [Abstract][Full Text] [Related]
4. Functionally active recombinant alpha and beta chain-peptide complexes of human major histocompatibility class II molecules.
Nag B; Arimilli S; Mukku PV; Astafieva I
J Biol Chem; 1996 Apr; 271(17):10413-8. PubMed ID: 8626615
[TBL] [Abstract][Full Text] [Related]
5. Separation of complexes of major histocompatibility class II molecules and known antigenic peptide by metal chelate affinity chromatography.
Nag B; Mukku PV; Arimilli S; Kendrick T; Deshpande SV; Sharma SD
J Immunol Methods; 1994 Mar; 169(2):273-85. PubMed ID: 7510762
[TBL] [Abstract][Full Text] [Related]
6. Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex.
Krogsgaard M; Wucherpfennig KW; Cannella B; Hansen BE; Svejgaard A; Pyrdol J; Ditzel H; Raine C; Engberg J; Fugger L
J Exp Med; 2000 Apr; 191(8):1395-412. PubMed ID: 10770805
[TBL] [Abstract][Full Text] [Related]
7. Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones.
Wucherpfennig KW; Sette A; Southwood S; Oseroff C; Matsui M; Strominger JL; Hafler DA
J Exp Med; 1994 Jan; 179(1):279-90. PubMed ID: 7505801
[TBL] [Abstract][Full Text] [Related]
8. Antigen-specific apoptosis in immortalized T cells by soluble MHC class II-peptide complexes.
Arimilli S; Mumm JB; Nag B
Immunol Cell Biol; 1996 Feb; 74(1):96-104. PubMed ID: 8934660
[TBL] [Abstract][Full Text] [Related]
9. Synthetic peptides that inhibit binding of the myelin basic protein 85-99 epitope to multiple sclerosis-associated HLA-DR2 molecules and MBP-specific T-cell responses.
Fridkis-Hareli M; Stern JN; Fugger L; Strominger JL
Hum Immunol; 2001 Aug; 62(8):753-63. PubMed ID: 11476898
[TBL] [Abstract][Full Text] [Related]
10. Peptide binding inhibits aggregation of soluble MHC class II in solution.
Arimilli S; Astafieva I; Mukku PV; Cardoso C; Deshpande S; Nag B
IUBMB Life; 1999 Nov; 48(5):483-91. PubMed ID: 10637763
[TBL] [Abstract][Full Text] [Related]
11. T cell response to myelin basic protein in the context of the multiple sclerosis-associated HLA-DR15 haplotype: peptide binding, immunodominance and effector functions of T cells.
Vergelli M; Kalbus M; Rojo SC; Hemmer B; Kalbacher H; Tranquill L; Beck H; McFarland HF; De Mars R; Long EO; Martin R
J Neuroimmunol; 1997 Aug; 77(2):195-203. PubMed ID: 9258250
[TBL] [Abstract][Full Text] [Related]
12. Structure of human T-cell receptors specific for an immunodominant myelin basic protein peptide: positioning of T-cell receptors on HLA-DR2/peptide complexes.
Wucherpfennig KW; Hafler DA; Strominger JL
Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8896-900. PubMed ID: 7568039
[TBL] [Abstract][Full Text] [Related]
13. Design, engineering, and production of human recombinant t cell receptor ligands derived from human leukocyte antigen DR2.
Chang JW; Mechling DE; Bächinger HP; Burrows GG
J Biol Chem; 2001 Jun; 276(26):24170-6. PubMed ID: 11319230
[TBL] [Abstract][Full Text] [Related]
14. Expression and crystallization of the complex of HLA-DR2 (DRA, DRB1*1501) and an immunodominant peptide of human myelin basic protein.
Gauthier L; Smith KJ; Pyrdol J; Kalandadze A; Strominger JL; Wiley DC; Wucherpfennig KW
Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11828-33. PubMed ID: 9751750
[TBL] [Abstract][Full Text] [Related]
15. Localization of soluble major histocompatibility class II-peptide complexes on T cell surface.
Arimilli S; Deshpande S; Nag B
Microsc Res Tech; 2000 Sep; 50(5):419-24. PubMed ID: 10941178
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two HLA-DR2 proteins.
Li Y; Li H; Martin R; Mariuzza RA
J Mol Biol; 2000 Nov; 304(2):177-88. PubMed ID: 11080454
[TBL] [Abstract][Full Text] [Related]
17. Naturally processed HLA class II peptides reveal highly conserved immunogenic flanking region sequence preferences that reflect antigen processing rather than peptide-MHC interactions.
Godkin AJ; Smith KJ; Willis A; Tejada-Simon MV; Zhang J; Elliott T; Hill AV
J Immunol; 2001 Jun; 166(11):6720-7. PubMed ID: 11359828
[TBL] [Abstract][Full Text] [Related]
18. Purified beta-chain of MHC class II binds to CD4 molecules on transfected HeLa cells.
Nag B; Wada HG; Passmore D; Clark BR; Sharma SD; McConnell HM
J Immunol; 1993 Feb; 150(4):1358-64. PubMed ID: 8432982
[TBL] [Abstract][Full Text] [Related]
19. Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients. Identity of key contact residues in the B-cell and T-cell epitopes.
Wucherpfennig KW; Catz I; Hausmann S; Strominger JL; Steinman L; Warren KG
J Clin Invest; 1997 Sep; 100(5):1114-22. PubMed ID: 9276728
[TBL] [Abstract][Full Text] [Related]
20. Binding of copolymer 1 and myelin basic protein leads to clustering of class II MHC molecules on antigen-presenting cells.
Fridkis-Hareli M; Teitelbaum D; Pecht I; Arnon R; Sela M
Int Immunol; 1997 Jul; 9(7):925-34. PubMed ID: 9237101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
